A Multicenter, Randomized, Double-blinded, Parallel, Placebo-controlled, Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of Intra-articular YY1201 Once in the Treatment of Patients With Osteoarthritis of the Knee

Trial Profile

A Multicenter, Randomized, Double-blinded, Parallel, Placebo-controlled, Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of Intra-articular YY1201 Once in the Treatment of Patients With Osteoarthritis of the Knee

Withdrawn prior to enrolment
Phase of Trial: Phase I/II

Latest Information Update: 19 Nov 2016

At a glance

  • Drugs YY 1201 (Primary)
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Sponsors Yoo Young Pharmaceutical
  • Most Recent Events

    • 02 Nov 2016 Planned End Date changed from 1 Sep 2016 to 1 Oct 2016.
    • 02 Nov 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Oct 2016.
    • 02 Nov 2016 Status changed from recruiting to withdrawn prior to enrolment.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top